Answers are grounded in this paper and cite their sources.
Phosphatidylserine (PS) exposure by red blood cells (RBCs) promotes endothelial adhesion and coagulation in sickle cell disease (SCD), but how membrane lipid remodelling influences Ca 2+ -associated PS exposure remains unclear. We hypothesise that variable coupling between Ca 2+ entry, notably via the mechanosensitive cation channel PIEZO1, and PS scrambling is important in pathogenesis. Simultaneous Fluo-4/lactadherin-Alexa Fluor 647 flow cytometry was used to measure intracellular Ca 2+ and PS exposure in RBCs from patients homozygous for SCD (HbSS genotype) following exposure to C6-ceramide or sphingomyelinase (SMase). The effect of ceramide was also investigated on responses to the PIEZO1 agonists Yoda1 and Yaddle1. Ceramide increased PS exposure in the presence of extracellular Ca 2+ but not when it was absent. Following 10 min exposure, ceramide increased the Fluo-4⁺/PS⁺ population and median Fluo-4 fluorescence intensity (MFI) in PS + cells, whereas after 5 h, PS exposure remained elevated at 100 µM without a significant difference in MFI between PS + and PS - cells. SMase also increased PS exposure and produced a different Fluo-4/PS distribution, while responses were minimal in Ca 2+ -free conditions. Ceramide pre-treatment markedly enhanced Yoda1-evoked Ca 2+ increases and PS exposure, particularly at submaximal concentrations, and increased Yaddle1-evoked Fluo-4 fluorescence and the Fluo-4⁺/PS⁺ population at 8 and 16 µM. Benzbromarone and Dooku1 attenuated agonist-evoked responses. These findings show that sphingolipid remodelling alters the pattern of intracellular Ca 2+ and PS responses in HbSS RBCs.
No takes yet. Share an insight, caveat, or question.
Gibson et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: